Lesion | Subject | Age (y) | Histology | TNM stage | Lesion size (cm3 on PET) | Lesion size (cm3 on CT) | SUVmean* | SUVmax* |
1 | 3 | 52 | Adenocarcinoma | Intravenous | 0.52 | 1.15 | 3.25 | 4.33 |
2 | 8 | 80 | Adenocarcinoma | Intravenous | 0.94 | 0.43 | 1.31 | 1.79 |
3 | 10 | 68 | SCC | Intravenous | 2.72 | 4.31 | 8.01 | 11.17 |
4 | 13 | 74 | Adenocarcinoma | Intravenous | 0.18 | 0.73 | 6.37 | 8.29 |
5 | 0.24 | 0.15 | 1.95 | 2.53 | ||||
6 | 14 | 71 | Adenocarcinoma | Intravenous | 1.80 | 7.15 | 12.33 | 16.93 |
7 | 2.73 | 6.60 | 11.14 | 15.69 | ||||
8 | 17 | 64 | Presumed NSCLC† | I | 0.53 | 2.70 | 6.43 | 8.63 |
9 | 19 | 58 | SCC | IIIB | 3.80 | 7.00 | 18.63 | 26.44 |
10 | 20 | 68 | Adenocarcinoma | Intravenous | 0.24 | 0.18 | 1.81 | 2.41 |
11 | 0.52 | 0.62 | 1.72 | 2.35 | ||||
12 | 0.79 | 0.34 | 1.42 | 1.95 |